Literature DB >> 11275994

Lymphoproliferative disorders in renal transplant patients in Japan.

Y Hoshida1, T Li, Z Dong, Y Tomita, A Yamauchi, J Hanai, K Aozasa.   

Abstract

Post-transplantation lymphoproliferative disorders (PT-LPD) are characterized by a clinically and morphologically heterogeneous group of lymphoid proliferation occurring after organ or bone marrow transplantation. The immunodeficient state provides a basis for lymphomagenesis probably through activation of oncogenic viruses. Twenty-four patients in whom PT-LPD developed after renal transplantation in Japan were analyzed. They received hemodialysis for 4 to 226 (median 13) months before transplantation. In situ hybridization was performed to detect Epstein-Barr virus (EBV). Polymerase chain reaction and Southern hybridization with primers in the tax and pol regions of human T-cell leukemia virus type I (HTLV-1) were performed on DNA extracted from paraffin-embedded specimens. Immunohistochemical analysis revealed that 12 cases were B-cell type, 10 cases (42%) T-cell type and 2 NK-cell type. Five of the T-cell cases were classified as adult T-cell lymphoma with proven HTLV-1 genome in the tumor and seropositivity for the virus. These cases were classified as adult T-cell lymphoma (ALT). More than 80% of B-cell, 30% of T-cell and both NK/T-cell lymphomas were EBV-positive. Co-infection of EBV and HTLV-1 was found in 2 cases with ATL. These findings showed that ATL is common among Japanese renal transplant patients, which might be due to transmission of HTLV-1 via blood transfusion during hemodialysis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275994     DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1125>3.0.co;2-n

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 2.  Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder.

Authors:  Ajay Major; Manali Kamdar
Journal:  Curr Treat Options Oncol       Date:  2018-05-24

Review 3.  Nasal-type NK/T-cell lymphoma with palatal ulcer as the earliest clinical manifestation: a case report with literature review.

Authors:  Wenxia Meng; Yu Zhou; Hengyu Zhang; Lu Jiang; Zhi Wang; Xiaoying Li; Hongmei Zhou; Qianming Chen; Xin Zeng
Journal:  Pathol Oncol Res       Date:  2009-07-11       Impact factor: 3.201

Review 4.  Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review.

Authors:  V Costes-Martineau; C Delfour; S Obled; L Lamant; G-P Pageaux; P Baldet; P Blanc; G Delsol
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

5.  Post-transplant lymphoproliferative disorder in paediatric patients: the Irish perspective-a single centre experience.

Authors:  A Malone; G Kennedy; L Storey; A O'Marcaigh; M McDermott; A M Broderick; O P Smith
Journal:  Ir J Med Sci       Date:  2016-02-29       Impact factor: 1.568

6.  Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients.

Authors:  Jesse Cheng; Cody A Moore; Carlo J Iasella; Allan R Glanville; Matthew R Morrell; Randall B Smith; John F McDyer; Christopher R Ensor
Journal:  Clin Transplant       Date:  2018-03-30       Impact factor: 2.863

7.  Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation.

Authors:  Fan Yang; Ying Li; Raul Braylan; Stephen P Hunger; Li-Jun Yang
Journal:  Pediatr Blood Cancer       Date:  2008-02       Impact factor: 3.167

Review 8.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

9.  EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies.

Authors:  Deirdre O'Mahony; John C Morris; Maryalice Stetler-Stevenson; Helen Matthews; Margaret R Brown; Thomas Fleisher; Stefania Pittaluga; Mark Raffeld; Paul S Albert; Dirk Reitsma; Karen Kaucic; Luz Hammershaimb; Thomas A Waldmann; John E Janik
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

10.  Post cardiac transplantation T-cell lymphoproliferative disorder presenting as a solitary lung nodule.

Authors:  Barina Aqil; Bhuvaneswari Krishnan; Choladda V Curry; M Tarek Elghetany; Reka Szigeti
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.